New rumor–is Qiagen in play?
This is a new rumor, but we have heard it only from one source, so you should take it with a grain of salt for now. I would not recommend you invest your life savings on this bit of news.
Qiagen stock rose 6 percent on Friday due to persistant rumors that Sanofi-Aventis is looking to [...]
Price Changes on Common Stock of life science equipment companies over the last three months.
Curious to see how your company stock has fared in the last three months as compared to your competitors? We were wondering who had done well and who hadn’t, so we decided to do a comparison. I wouldn’t lose too much sleep if one of your competitors beat your company out by a few percentage [...]
They must be doing something right at Abbott.
I just took a quick peek at Abbotts recently released financial numbers for last year. Outstanding.
They report double-digit growth in both sales and earnings for 2008. They are also predicting a very strong earnings outlook for FY 2009 as well.
Overall Worldwide sales were up 10.1%. Adjusted earnings per share was up 14%. They had double digit [...]
FDA moves on Geron’s request for trials much more quickly than expected.
Back on January 11, I had written an article on Geron Corp and the possiblilty that the FDA would give them the OK to begin clinical trials. In the article I had mentioned that Geron would be a good company to invest in, but that I didn’t expect the FDA to rush things along. Well, [...]
Here’s a company you might want to look at investing in with your “mad money.”
Geron Corp out of Menlo Park, California is, to the best of my knowledge, the first company to be on the verge of being approved by the FDA to do clinical trials on a stem cell derived treatment for spinal injury.
When the Bush Administration went after funding for stem cell research several years ago, most [...]
Big biotech stocks were a safe haven in 2008.
While big pharma has done fairly well overall, the medium to large biotechs were a good place to be in 2008.
Because many of the products made by biotechs are viewed by both patients and doctors as being lifesaving technologies, demand was less affected by a poor economy. Plus, unlike the big pharma companies, who must contend [...]
First trading day of 2009 a good one for the stock market. Only 363 more days to next New Years Eve.
In reality, one day in the life of the stock market means very little, but we might as well start off the New Year with some good news.
The Dow was up today 258.30 or 2.94% to 9,034.69. It finished the week up 6.1%. The last time the Dow closed over 9000 was back on November [...]
Biotech equipment company stock prices mixed for December
At the beginning of each month, GenomeWeb has an interesting piece describing how the stocks of the major biotech tools companies did the previous month. December was a mixed bag, with the stocks overall being up slightly.
The two best performers in the market were Pressure Biosciences up 45.83% and Monogram Biosciences up 31.31%. Sequenom was [...]
While CRO’s as a whole are doing well, there are some exceptions
Recently I had touted CRO’s as doing well. And, as a group they are. But like any grouping of companies, there are always a few dogs in the pound.
PharmaNet Development Group, based out of Princeton, New Jersey recently put out a press release stating that they are working with a Financial Adviser from USB in an [...]
Pharma industry investment opportunities changing.
In the past, investing in the pharmaceutical industry was pretty easy. Pick a couple of major drug makers and watch your investment grow. Due to market conditions and political considerations, things are changing.
Overall growth globally for the pharmaceutical industry is predicted to be in the 4 to 6% range. This is due to many factors. The [...]
Email delivery